Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC).


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 2 6 2020
medline: 6 8 2020
entrez: 2 6 2020
Statut: ppublish

Résumé

Regular exercise has multiple benefits for physical and mental health, including the body's ability to combat infections. The current COVID-19 pandemic and the social distancing measures employed to curtail the impact of the infection are likely to reduce the amount of usual physical activity being performed by most individuals, including habitual exercisers. The uncertainties relating to the impact of the SARS-CoV-2 virus on the heart may cause increased anxiety, particularly in athletes who need to sustain a vigorous exercise regime in order to maintain their skills and fitness in preparation for return to competition after a short re-training period. The aim of this document is to provide practical answers to pertinent questions being posed by the sporting community, in an attempt to offer reassurance, promote safe participation in exercise during as well as after the COVID-19 pandemic and provide a framework of management for physicians caring for athletes.

Identifiants

pubmed: 32475157
doi: 10.1177/2047487320930596
pmc: PMC7717284
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1242-1251

Commentaires et corrections

Type : CommentIn

Références

JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Med Sci Sports Exerc. 2001 Apr;33(4):549-55
pubmed: 11283429
Med Sci Sports Exerc. 2006 Jan;38(1):173-8
pubmed: 16394971
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet Infect Dis. 2020 Jul;20(7):773
pubmed: 32171390
Eur Heart J. 2019 Jan 1;40(1):19-33
pubmed: 30561613
Exerc Immunol Rev. 2020;26:8-22
pubmed: 32139352
Int J Sports Med. 1990 Dec;11(6):467-73
pubmed: 2286486
Br J Sports Med. 2019 Sep;53(17):1093-1098
pubmed: 31142472
Curr Sports Med Rep. 2011 Mar-Apr;10(2):84-9
pubmed: 21623289
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Eur Heart J. 2020 May 14;41(19):1861-1862
pubmed: 32267502
PLoS One. 2008 May 07;3(5):e2108
pubmed: 18461130
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Exerc Sport Sci Rev. 2009 Oct;37(4):157-64
pubmed: 19955864
Br J Sports Med. 2020 Feb;54(4):216-220
pubmed: 31810972
Psychosom Med. 2006 Mar-Apr;68(2):224-30
pubmed: 16554387
Trends Pharmacol Sci. 2004 Jun;25(6):291-4
pubmed: 15165741
Acta Med Scand. 1983;213(1):65-73
pubmed: 6829323
JAMA Cardiol. 2020 Jul 1;5(7):751-753
pubmed: 32219362

Auteurs

Raghav T Bhatia (RT)

Cardiology Clinical Academic Group, St George's, University of London, UK.

Sarandeep Marwaha (S)

Cardiology Clinical Academic Group, St George's, University of London, UK.

Aneil Malhotra (A)

Division of Cardiovascular Science, University of Manchester, Manchester University NHS Foundation Trust, UK.

Zafar Iqbal (Z)

Department of Sports Medicine, Crystal Palace FC, London, UK.

Christopher Hughes (C)

Medical department, Tottenham Hotspur FC, London, UK.

Mats Börjesson (M)

Department of Molecular and Clinical Medicine Institute of Medicine, Centre for Health and Performance, Gothenburg University and Sahlgrenska University Hospital/Ostra, Gothenburg, Sweden.

Josef Niebauer (J)

Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg, Austria.

Antonio Pelliccia (A)

Institute of Sports Medicine and Science, Rome, Italy.

Christian Schmied (C)

University Heart Centre, Zurich, Switzerland.

Luis Serratosa (L)

Hospital Universitario Quironsalud Madrid, Spain *These authors contributed jointly as senior authors.

Michael Papadakis (M)

Cardiology Clinical Academic Group, St George's, University of London, UK.

Sanjay Sharma (S)

Cardiology Clinical Academic Group, St George's, University of London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH